Clinical Trial Update: A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery Disease [Phase 1]

View source ↗

Summary

Phase I trial in healthy volunteers assessing the safety of CardioPET™ imaging agent for detecting coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CardioPET™

Snippet

Sponsor: Fluoropharma, Inc. | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED